Akron Bio Appoints Christopher Murphy as Chief Executive Officer

BOCA RATON, Fla. & SARASOTA, Fla.–Akron Bio (“Akron”), a provider of critical inputs for cell and gene therapies, today announced the appointment of Christopher Murphy as Chief Executive Officer. Akron is a portfolio company of Arcline Investment Management. Mr. Murphy is a biotechnology industry veteran with more than 30 years of experience in advanced therapy […]

This website uses cookies to improve your experience. By using this website, you accept our use of cookies. Read More

Collaboration is the key to innovation. How will we work together?